Therapeutic angiogenesis and vasculogenesis for ischemic disease - Part II: Cell-based therapies

被引：302

作者：

Losordo, DW

Dimmeler, S

机构：

[1] St Elizabeths Med Ctr, Brighton, MA 02135 USA

[2] Goethe Univ Frankfurt, Dept Mol Cardiol, D-6000 Frankfurt, Germany

来源：

CIRCULATION | 2004年 / 109卷 / 22期

关键词：

angiogenesis; neovascularization;

D O I：

10.1161/01.CIR.0000128596.49339.05

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2692 / 2697

页数：6

共 50 条

[1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].

AIELLO, LP ;

AVERY, RL ;

ARRIGG, PG ;

KEYT, BA ;

JAMPEL, HD ;

SHAH, ST ;

PASQUALE, LR ;

THIEME, H ;

IWAMOTO, MA ;

PARK, JE ;

NGUYEN, HV ;

AIELLO, LM ;

FERRARA, N ;

KING, GL .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487

[2] Isolation of putative progenitor endothelial cells for angiogenesis [J].

Asahara, T ;

Murohara, T ;

Sullivan, A ;

Silver, M ;

vanderZee, R ;

Li, T ;

Witzenbichler, B ;

Schatteman, G ;

Isner, JM .

SCIENCE, 1997, 275 (5302) :964-967

[3] VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells [J].

Asahara, T ;

Takahashi, T ;

Masuda, H ;

Kalka, C ;

Chen, DH ;

Iwaguro, H ;

Inai, Y ;

Silver, M ;

Isner, JM .

EMBO JOURNAL, 1999, 18 (14) :3964-3972

[4] Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI) [J].

Assmus, B ;

Schächinger, V ;

Teupe, C ;

Britten, M ;

Lehmann, R ;

Döbert, N ;

Grünwald, F ;

Aicher, A ;

Urbich, C ;

Martin, H ;

Hoelzer, D ;

Dimmeler, S ;

Zeiher, AM .

CIRCULATION, 2002, 106 (24) :3009-3017

[5] Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI) -: Mechanistic insights from serial contrast-enhanced magnetic resonance imaging [J].

Britten, MB ;

Abolmaali, ND ;

Assmus, B ;

Lehmann, R ;

Honold, J ;

Schmitt, J ;

Vogl, TJ ;

Martin, H ;

Schächinger, V ;

Dimmeler, S ;

Zeiher, AM .

CIRCULATION, 2003, 108 (18) :2212-2218

[6] Vascular endothelial growth factor enhances atherosclerotic plaque progression [J].

Celletti, FL ;

Waugh, JM ;

Amabile, PG ;

Brendolan, A ;

Hilfiker, PR ;

Dake, MD .

NATURE MEDICINE, 2001, 7 (04) :425-429

[7] Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice [J].

Couffinhal, T ;

Silver, M ;

Kearney, M ;

Sullivan, A ;

Witzenbichler, B ;

Magner, M ;

Annex, B ;

Peters, K ;

Isner, JM .

CIRCULATION, 1999, 99 (24) :3188-3198

[8]

de Bont ESJM, 2001, CANCER RES, V61, P7654

[9] Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells [J].

De Palma, M ;

Venneri, MA ;

Roca, C ;

Naldini, L .

NATURE MEDICINE, 2003, 9 (06) :789-795

[10] HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway [J].

Dimmeler, S ;

Aicher, A ;

Vasa, M ;

Mildner-Rihm, C ;

Adler, K ;

Tiemann, M ;

Rütten, H ;

Fichtlscherer, S ;

Martin, H ;

Zeiher, AM .

JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :391-397

← 1 2 3 4 5 →